Press

06/16/2010Vicus Therapeutics Announces Positive Results of Phase 2 Trial of VT-122 for the treatment of Cachexia in Patients with Advanced Lung Cancer and presented at ASCO 2010 ...View press release

03/31/2009Vicus Therapeutics Announces Acceptance of Abstract at ASCO 2010 for Phase 2  Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer ...View press release

04/16/2009Vicus Therapeutics Announces Submission of Final Study Report for Phase 2  Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer ...View press release

04/16/2008Vicus Therapeutics Announces Last Patient Out of Phase 2  Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer ...View press release

01/16/2007Vicus Therapeutics Announces FDA Approval of Phase 2 Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer ...View press release